Risk, returns & timeframes illustration
1 min read
March 8, 2022
by

Is beauty getting lippy?

We’re swapping masks for lippy as global restrictions lift. 💄 Who’s sitting pretty and who’s stock price sagged over Covid? 👄
1 min read
March 8, 2022
by

Is beauty getting lippy?

We’re swapping masks for lippy as global restrictions lift. 💄 Who’s sitting pretty and who’s stock price sagged over Covid? 👄
1 min read
March 8, 2022
by

Is beauty getting lippy?

We’re swapping masks for lippy as global restrictions lift. 💄 Who’s sitting pretty and who’s stock price sagged over Covid? 👄
Table of contents
Getting Started Investing course
Free Getting Started Course
Take your first, or next, step to becoming a confident investor with Hatch's free online course – just 10 minutes a day, for 10 days.

Suffragette Elizabeth Arden knew the collective power of a red lip.  And more than a century after 15,000 women marched through NYC wearing the bold colour statement, some beauty brands are sitting pretty in the US share markets. While Arden’s brand hasn’t been making a splash in the markets during the mask-wearing years, other beauty companies have shown they’re not just a pretty face.

Estée Lauder (EL) has been getting better with age, climbing 1649.5% since 2009. Founded by beauty pioneer of the same name, Estée Lauder saw 30.9% wiped off their share price in March 2020 but have since dropped shade on competitors, rising 30.7% higher than their pre-Covid peak. Despite having reduced margins to temper inflation, as Covid restrictions have waned, Estée Lauder has seen a surge in makeup sales as lipstick’s replaced masks. 💄

It’s bunnies for the win as cruelty-free cosmetics company ELF (ELF) is showing beauty’s more than skin deep, passing through the global pandemic with flying colours, up 26.6% since their pre-Covid peak. While having walked a rockier road, ULTA (ULTA) - the Sephora without the influencer #squad - also boasts a worthy before and after picture. 📸 Despite sagging March 2020, they’ve stretched back 22.5% since their pre-covid high. 

But not all beauty companies have scrubbed up. Revlon (REV), which made their debut on the NYSE in 1932 between two world wars, has drooped -62.34% since their 2020 high. Despite posting a 2021 revenue recovery, their $3.3 billion debt has taken the shine off growth. Brazilian Natura & Co (NTCO), which owns The Body Shop and Aesop - and had to navigate running a business in a country with the world’s third-highest Covid death rates - washed -62.6% off their pre-pandemic value. And self-proclaimed disruptor Coty (COTY), which has among their founders Max Factor and Sally Hansen, has plunged -33.3% from pre-WFH 2020 highs, reporting that their profit beat expectations, but their revenue failed to hit the mark. 💅🏻

We’re not financial advisors and Hatch news is for your information only. However dazzling our writing, none of it is a recommendation to invest in any of the companies or funds mentioned. If you want support before making any investment decisions, consider seeking financial advice from a licensed provider. We’ve done our best to ensure all information is current when we pushed ‘publish’ on this article. And of course, with investing, your money isn’t guaranteed to grow and there’s always a risk you might lose money.

Join the Kiwis who are hatching their tomorrow and have invested more than $1 billion with Hatch.

Explore another series
Tax
Money
Economy
Investing

More recent news articles

Recent learn articles

8 min read
Mar 25, 2025

What’s driving gold prices to record highs?

As the world waits for Trump’s tariffs policies to take effect, the allure of gold has sent bullion, stocks and ETFs to glittering highs. But could gold’s volatility and the potential for the US to sell its gold reserves to buy bitcoin prime other global central banks to do the same?
Read more
8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more
7 min read
Feb 12, 2025

Trump’s trade tariffs and the AI race

US President Trump has swept into the Oval Office proposing what some have called ‘punitive’ tariffs with its three largest trading partners, China, Canada and Mexico. But could tariffs plug America's massive deficit? And is there an even greater agenda to do with the trillion dollar AI race?
Read more

Related news articles

More recent learn articles

No items found.

Recent news articles

More recent learn articles

8 min read
Mar 25, 2025

What’s driving gold prices to record highs?

As the world waits for Trump’s tariffs policies to take effect, the allure of gold has sent bullion, stocks and ETFs to glittering highs. But could gold’s volatility and the potential for the US to sell its gold reserves to buy bitcoin prime other global central banks to do the same?
Read more
8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more
7 min read
Feb 12, 2025

Trump’s trade tariffs and the AI race

US President Trump has swept into the Oval Office proposing what some have called ‘punitive’ tariffs with its three largest trading partners, China, Canada and Mexico. But could tariffs plug America's massive deficit? And is there an even greater agenda to do with the trillion dollar AI race?
Read more